Precision immunogenicity
for every patient.
From personalized cancer vaccines for patients to immunogenicity prediction for life sciences programs.
Your most personalized cancer treatment.
We leverage our technology platform to design and deliver personalized cancer vaccines to eligible patients through the FDA's Expanded Access pathway.
The End-to-End Process at a Glance
Sequence
We can work with sequencing data you have already gathered, or facilitate whole-exome sequencing of your tumor, matched normal tissue, and HLA typing to map your unique genetic landscape.
Authorize
We work with our physician network or your preferred medical team to help navigate the FDA Expanded Access (Compassionate Use) Program.
Design
Our machine learning model identifies the highest value neoantigen targets most likely to catalyze your body's healing power to fight your tumor.
Manufacture
We coordinate peptide and/or mRNA vaccine manufacturing with a clinical-grade manufacturing partner.
Administer & Monitor
The vaccine series is delivered to your treating physician. Immune monitoring confirms your body's therapeutic response.
Ready to get started?
Whether you are a patient exploring options or a life sciences team with a program in development, we want to hear from you.